🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Drug X Context, instead of Drug + Context Psychedelics ARE NOT the new paradigm, but the anomaly which questions the old paradigm An interactive paradigm is relevant to all psychoactive drugs A lot is at risk here - including the RCT as we know it journals.sagepub.com/doi/full/10.11…

Immensely excited by the publication of “The mindful use of psychiatric medication,” a new and groundbreaking paper that demonstrates how the the concept of set and setting can be integrated into psychiatric care to improve safety, satisfaction and efficacy while reducing abuse

New in Nature Medicine: ReSPCT "An international Delphi consensus for reporting of setting in psychedelic clinical trials" by Chloé Pronovost-Morgan, Kyle Greenway, myself, and many ReSPCT Experts. "The ReSPCT guidelines and accompanying explanatory document provide a new standard for

As psychedelics gain traction as potential treatments for mental health disorders, an international study co-led by McGill University researchers stands to improve the rigour and reliability of clinical research. mcgill.ca/newsroom/chann…

A great step toward standardizing reporting of extrapharmacologic factors in psychedelic trials! Congrats Chloé Pronovost-Morgan Leor Roseman 🦋 @leorroseman.bsky.social et al nature.com/articles/s4159…

🚨🍄 Major new preprint alert 🍄🚨 I think these will be important results. They are not going make me popular with my #psychedelic in-group, please do not shoot the messenger! The premise of this pre-registered meta analysis (osf.io/preprints/psya…) is that it is biased to

Psychedelic researchers establish new ReSPCT guidelines, emphasizing crucial environmental factors for improved clinical trial reporting and methodology. by Pronovost-Morgan C, Greenway KT and Roseman L in Nat Med nature.com/articles/s4159… #MedX #MedResearch

For those of you who would like to use the new Reporting of Setting in Psychedelic Clinical Trials (ReSPCT) guidelines, we’ve created a user-friendly website to help you navigate the guidelines: 👉 Wesbite: respctguidelines.com 👉 Paper: nature.com/articles/s4159… On the site,